Lanean...
Cancer immunotherapy: moving forward with peptide T cell vaccines
Recent advances in cancer immunology, such as the discovery of immune checkpoint inhibitors, have validated immune cells as potential key players for effective cancer treatment. The efficacy of these therapies seems to be codependent on a tumor-reactive T lymphocyte response. For many years, numerou...
Gorde:
| Argitaratua izan da: | Curr Opin Immunol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5626598/ https://ncbi.nlm.nih.gov/pubmed/28734176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2017.07.003 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|